Table 1.
OX40-targeted drugs
Type | Drug |
Humanised IgG1 agonist mAb | ABBV-368 |
GSK3174998 | |
MEDI0562 | |
MOXR0916 (vonlerolizumab) | |
Fully human IgG1 agonist mAb | INCAGN01949 |
IBI101 | |
BMS-986178 | |
Fully human IgG2 agonist Ab | PF-04518600 |
Murine IgG1 agonist mAb | MEDI6469P |
9B12 | |
Human IgG1 CTLA-4 × OX40 bispecific Ab | ATOR-1015 |
Lipid nanoparticle encapsulating mRNAs encoding human OX40L, IL-23 and IL-36γ | mRNA-2752 |
Human OX40L IgG4P Fc fusion protein | MEDI6383 |
Dual-sided Fc fusion protein PD1-Fc-OX40L | SL-279252 |
Ab, antibodies; IL, interleukin; mAb, monoclonal antibodies.